Case report: One case of refractory membranous nephropathy with hypokalemia after rituximab infusion was switched to obinutuzumab without recurrence of hypokalemia.

Front Pharmacol · 2024 · PMC10853342 · PMID 38344176

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Although a decreasing trend in PLA2R and urinary proteins was observed with the subsequent addition of 0.5 g of RTX, the patient developed hypokalemia while receiving the last 0.5 g of RTX.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.